Status:

COMPLETED

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

Lead Sponsor:

French National Agency for Research on AIDS and Viral Hepatitis

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

HIV Infection

Tuberculosis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

In Cambodia the prevalence of both tuberculosis (TB) and Human Immunodeficiency Virus (HIV) infection is high. Data suggest that aggressive management of HIV infection, which includes Anti-Retroviral ...

Detailed Description

In Cambodia the prevalence of both tuberculosis (TB) and Human Immunodeficiency Virus (HIV) infection is high. In 2000, there were approximately 75.000 newly diagnosed TB cases. In 2003, 1.9% of the p...

Eligibility Criteria

Inclusion

  • Age 18 or over
  • Positive HIV test result
  • CD4+ cell count under or equal to 200 cells per ml within 14 days prior the study entry
  • Positive AFB on any smear (sputum, lymph node drainage, stool, CSF, pleural fluid)
  • Naive to ART
  • TB treatment started less than one week prior enrolment
  • Negative gonadotrophin pregnancy test (blood) for women of childbearing potential (i.e. not surgically sterile or less than 2 years menopause)
  • Agreement from female candidates who are participating in sexual activity that could lead to pregnancy while receiving and for 6 weeks after stopping efavirenz to use two reliable methods of contraception, one of which including condom.

Exclusion

  • Suspected TB with negative AFB
  • Pregnant or breastfeeding women
  • Impaired hepatic function (icterus, elevated AST or ALT at least 5 times over the normal value)
  • Unable and/or unlikely to comprehend and/or be adherent to the protocol
  • Treated for a previous suspected or documented TB other than the ongoing infection which motivates enrolment in this trial

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

661 Patients enrolled

Trial Details

Trial ID

NCT00226434

Start Date

January 1 2006

End Date

May 1 2010

Last Update

March 16 2012

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Calmette Hospital

Phnom Penh, Cambodia

2

Khmero-Soviet Friendship Hospital

Phnom Penh, Cambodia

3

Siem Reap Referral Hospital

Siem Reap, Cambodia

4

Provincial hospital

Svay Rieng, Cambodia